Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma

Siegel, 2019, Cancer statistics, 2019, CA Cancer J. Clin., 69, 7, 10.3322/caac.21551 Alinezhad, 2019, Novel management of glioma by molecular therapies, a review article, Eur. J. Transl. Myol., 29, 8209, 10.4081/ejtm.2019.8209 Di Carlo, 2019, Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis, Neurosurg. Rev., 42, 263, 10.1007/s10143-017-0928-7 Daniel, 2019, Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities, Front. Oncol., 9, 41, 10.3389/fonc.2019.00041 Bahadur, 2019, Current promising treatment strategy for glioblastoma multiform: A review, Oncol. Rev., 13, 417, 10.4081/oncol.2019.417 Jiapaer, 2018, Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma, Neurol. Med. Chir. (Tokyo), 58, 405, 10.2176/nmc.ra.2018-0141 Taylor, 2018, Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma, Apoptosis, 23, 563, 10.1007/s10495-018-1480-9 Grek, 2018, Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics, Curr. Opin. Pharmacol., 41, 79, 10.1016/j.coph.2018.05.002 Huarte, 2015, The emerging role of lncRNAs in cancer, Nat. Med., 21, 1253, 10.1038/nm.3981 Wahlestedt, 2013, Targeting long non-coding RNA to therapeutically upregulate gene expression, Nat. Rev. Drug Discov., 12, 433, 10.1038/nrd4018 Yao, 2019, Cellular functions of long noncoding RNAs, Nat. Cell Biol., 21, 542, 10.1038/s41556-019-0311-8 Wang, 2019, Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells, Med. Sci. Monit., 25, 7567, 10.12659/MSM.916040 Zhang, 2014, Long non-coding RNAs in glioma: functional roles and clinical perspectives, Neurochem. Int., 77, 78, 10.1016/j.neuint.2014.05.008 Li, 2019, Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma, Cell Death Dis., 10, 717, 10.1038/s41419-019-1948-8 Liao, 2019, Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression, Mol. Ther. Nucleic Acids, 18, 388, 10.1016/j.omtn.2019.09.005 Xin, 2019, Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation, Pathol. Res. Pract., 215, 152539, 10.1016/j.prp.2019.152539 Wang, 2018, lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer, Cancer Cell, 33, 706, 10.1016/j.ccell.2018.03.006 Li, 2018, Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth, Biochem. Biophys. Res. Commun., 504, 654, 10.1016/j.bbrc.2018.08.174 Cui, 2019, LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells, OncoTargets Ther., 12, 7911, 10.2147/OTT.S209563 Li, 2019, lncRNA LINC01494 Promotes Proliferation, Migration And Invasion In Glioma Through miR-122-5p/CCNG1 Axis, OncoTargets Ther., 12, 7655, 10.2147/OTT.S213345 Zhang, 2018, Long non-coding RNA EPIC1 promotes human lung cancer cell growth, Biochem. Biophys. Res. Commun., 503, 1342, 10.1016/j.bbrc.2018.07.046 Zhao, 2019, Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation, Int. J. Biol. Macromol., 128, 566, 10.1016/j.ijbiomac.2019.01.156 Marucci, 2008, Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20, Virchows Arch., 453, 599, 10.1007/s00428-008-0685-7 Xie, 2015, CDC20 maintains tumor initiating cells, Oncotarget, 6, 13241, 10.18632/oncotarget.3676 Mao, 2015, A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells, Cell Rep., 11, 1809, 10.1016/j.celrep.2015.05.027 Wang, 2018, Systematic identification of non-coding pharmacogenomic landscape in cancer, Nat. Commun., 9, 3192, 10.1038/s41467-018-05495-9 Wang, 2017, Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition, Cell Cycle, 16, 2355, 10.1080/15384101.2017.1388972 Wang, 2019, miR-342 inhibits glioma cell proliferation by targeting GPRC5A, Mol. Med. Rep., 20, 252